Business Wire

MURFREESBORO, Tenn.--(BUSINESS WIRE)-- National HealthCare Corporation (NYSE American: NHC), a national leader in senior care, announced that on May 31, 2024 it entered a Purchase and Sale Agreement to acquire the White Oak Senior Living (“White Oak”) portfolio operating in North Carolina and South Carolina, including its long-term care pharmacy. White Oak’s portfolio consists of six skilled nursing facilities in North Carolina, three of which are continuing... (continue reading...)

LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor receptor-mutated (EGFR-mutated) non-small cell lung cancer (NCT04085315) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting currently being held in Chicago. The poster (Abstract #8572, Poster Bd #436), entitled, “A... (continue reading...)

• WIND-PSC will enroll up to 2000 patients with primary sclerosing cholangitis (PSC) across North America and Europe
• Study designed in collaboration with top global PSC experts and aligned with regulatory guidance for using real-world data to develop new treatments in rare diseases
• First patient-led clinical research project of its kind in liver diseases and launched solely with patient community funds

DENVER & TORONTO--(BUSINESS WIRE)-- PSC Partners and... (continue reading...)

Preliminary profile supports development of MYTX-011 in multiple subsets of NSCLC

WALTHAM, Mass.--(BUSINESS WIRE)-- Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, today announced initial dose escalation results from its ongoing Phase 1 KisMET-01 study evaluating its investigational cMET-targeting ADC, MYTX-011, in... (continue reading...)

Findings show clinical trial participation is not associated with suboptimal end of life care outcomes

THE WOODLANDS, Texas--(BUSINESS WIRE)-- To address a gap in knowledge surrounding clinical trial participation impacts on unplanned healthcare utilization and hospice enrollment in adults with cancer, investigators from The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient... (continue reading...)